Do you lose more weight on 5mg Mounjaro than on the starter dose?

What SURMOUNT-1 shows about dose and weight loss

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and followed them for 72 weeks. Participants were randomised to tirzepatide at 5mg, 10mg or 15mg, or to placebo. The 5mg group averaged around 15% body-weight reduction over the trial period. The 10mg group averaged roughly 19.5%, and the 15mg group around 20–21%. Every step up the dose ladder produced a meaningfully larger average loss.

That dose-response pattern is the clearest answer to the question. Five milligrams does more than 2.5mg. Ten does more than five. The relationship is not dramatic between adjacent doses, but it is consistent across the trial's thousands of participants. NICE cited this evidence directly when recommending tirzepatide for adults meeting the clinical criteria, a decision published in NICE Technology Appraisal TA1026.

One practical check that takes under a minute: find your current pen and note the dose on the label. Cross-referencing that with where you are in the titration schedule gives you and your prescriber a clear baseline to discuss at your next review.

Why 2.5mg is not designed to produce the same weight loss as 5mg

The licensed titration schedule begins at 2.5mg for a specific reason: tirzepatide's most common side effects are gastrointestinal (nausea, loose stools, indigestion) and they tend to be most noticeable when you first start or when your dose increases. The starter dose keeps those effects manageable while your gut adapts. It was not studied as a long-term maintenance dose, and the SmPC does not position it as one.

After four weeks, assuming 2.5mg has been well tolerated, the prescriber typically steps the dose to 5mg. From that point the medicine is working at a level the trial data associates with genuine weight reduction. For a fuller look at how 5mg compares with the starting pen, the page on how 5mg compares to 2.5mg covers the evidence in more detail. The distinction matters — framing 2.5mg as a weight-loss failure when it was never intended as a therapeutic ceiling is a common and understandable mistake.

Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, which together slow gastric emptying, dampen appetite signals and influence blood-sugar regulation. At lower doses these effects are present but modest; at higher doses they are more pronounced. That mechanism underpins the dose-response curve SURMOUNT-1 described.

Does losing more weight on a higher dose mean you should push to 15mg quickly?

Not necessarily. Prescribers titrate based on tolerability, not speed. Someone who moves too quickly through the dose steps is more likely to experience persistent nausea or other side effects that lead them to stop the medicine entirely, which produces no weight loss at all. A slower titration that reaches 10mg and stays there comfortably often delivers better real-world results than an accelerated schedule that stops at 7.5mg because side effects became unmanageable.

The question of whether you will lose more weight on higher doses of Mounjaro over time is one your prescriber is best placed to answer once they can see how you have responded to each step. If you are wondering about the broader pattern across doses, the page on higher doses and weight loss sets out what the trial evidence shows at each level.

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related health condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone does not guarantee a prescription; clinical suitability is assessed individually. You can read more about how the medicine is used in the UK on the Mounjaro treatment page.

What this means in practice if you are currently on 5mg

If you are on 5mg and feel your weight loss has slowed or stalled, that is worth raising at your next clinical review rather than drawing conclusions from a week or two of the scales. Weight loss on tirzepatide is rarely linear: some weeks show bigger drops, others are flat, and plateaus are a recognised feature of how the body responds to any sustained calorie deficit. If you want to understand whether you will lose more weight on 5mg Mounjaro as your time at this dose increases, the evidence from SURMOUNT-1 reflects averages across large groups over 72 weeks, and individual journeys vary considerably.

A few things your prescriber will consider before recommending a dose step: how you tolerated 2.5mg, whether 5mg side effects have settled, how long you have been at the current dose, and whether there are any clinical reasons to pause. This is also a good time to review dietary habits, tirzepatide suppresses appetite significantly, but protein intake and hydration still matter for preserving lean mass and managing side effects.

For context on the private cost of treatment across doses, the Mounjaro cost page covers what affects pricing in the UK private market. And if you are thinking about whether a clinically reviewed route might suit you, a free consultation with our prescribers is where that conversation starts, no waiting list, reviewed the same day.

Mounjaro is a prescription-only medicine. The NHS tirzepatide page has clear, plain-language information on how the medicine works, common side effects and what to watch for. If you are on 5mg and want a detailed look at how 5mg Mounjaro drives weight loss, that decision still sits with your prescriber rather than a general guide like this one. Check your eligibility through a free consultation with a GPhC-registered prescriber who can review your case the same day.